Literature DB >> 21605489

Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons.

Carlos A Vaz Fragoso1, Thomas M Gill, Gail McAvay, Peter H Van Ness, H Klar Yaggi, John Concato.   

Abstract

BACKGROUND: The lambda-mu-sigma (LMS) method calculates the lower limit of normal for spirometric values as the 5th percentile of the distribution of Z scores. Conceptually, LMS-derived Z scores account for normal age-related changes in pulmonary function, including variability and skewness in reference data. Evidence is limited, however, on whether the LMS method is valid for evaluating respiratory impairment in middle-aged persons.
OBJECTIVE: To evaluate the association of LMS-defined respiratory impairment (airflow limitation and restrictive pattern) with mortality and respiratory symptoms.
METHODS: We analyzed spirometric data from white participants ages 45-64 years in the Third National Health and Nutrition Examination Survey (NHANES III, n = 1,569) and the Atherosclerosis Risk in Communities study (ARIC, n = 8,163).
RESULTS: LMS-defined airflow limitation was significantly associated with mortality (adjusted hazard ratios: NHANES III 1.90, 95% CI 1.32-2.72, ARIC 1.28, 95% CI 1.06-1.57), and respiratory symptoms (adjusted odds ratios: NHANES III 2.48, 95% CI 1.75-3.51, ARIC 2.27, 95% CI 1.98-2.62). LMS-defined restrictive-pattern was also significantly associated with mortality (adjusted hazard ratios: NHANES III 1.98, 95% CI 1.08-3.65, ARIC 1.38, 95% CI 1.03-1.85), and respiratory symptoms (adjusted odds ratios: NHANES III 2.34, 95% CI 1.44-3.80, ARIC 1.89, 95% CI 1.46-2.45).
CONCLUSIONS: In white middle-age persons, LMS-defined airflow limitation and restrictive-pattern were significantly associated with mortality and respiratory symptoms. Consequently, an approach that reports spirometric values based on LMS-derived Z scores might provide an age-appropriate and clinically valid strategy for evaluating respiratory impairment.

Entities:  

Mesh:

Year:  2011        PMID: 21605489      PMCID: PMC3676885          DOI: 10.4187/respcare.01192

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  27 in total

1.  Short-term variation in air pollution and in average lung function among never-smokers. The Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA).

Authors:  C Schindler; N Künzli; J P Bongard; P Leuenberger; W Karrer; R Rapp; C Monn; U Ackermann-Liebrich
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

Review 3.  Epidemiology of COPD.

Authors:  C Raherison; P-O Girodet
Journal:  Eur Respir Rev       Date:  2009-12

4.  Pulmonary function testing in population-based studies.

Authors:  T A Manolio; G G Weinmann; A S Buist; C D Furberg; J L Pinsky; S H Hurd
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

5.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

6.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

7.  Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates.

Authors:  P Peduzzi; J Concato; A R Feinstein; T R Holford
Journal:  J Clin Epidemiol       Date:  1995-12       Impact factor: 6.437

Review 8.  Clinical use of bone densitometry: scientific review.

Authors:  Steven R Cummings; David Bates; Dennis M Black
Journal:  JAMA       Date:  2002-10-16       Impact factor: 56.272

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory.

Authors:  Christine A Glady; Shawn D Aaron; Mary Lunau; Jennifer Clinch; Robert E Dales
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

View more
  9 in total

1.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

Review 2.  Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-01       Impact factor: 6.053

Review 3.  Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) in Aging Populations.

Authors:  Carlos A Vaz Fragoso
Journal:  COPD       Date:  2015-12-02       Impact factor: 2.409

Review 4.  Epidemiology and management of common pulmonary diseases in older persons.

Authors:  Kathleen M Akgün; Kristina Crothers; Margaret Pisani
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-02-15       Impact factor: 6.053

5.  Phenotype of normal spirometry in an aging population.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Peter H Van Ness; Richard Casaburi; Robert L Jensen; Neil MacIntyre; Thomas M Gill; H Klar Yaggi; John Concato
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

6.  Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults.

Authors:  Sandy S Chang; Shu Chen; Gail J McAvay; Mary E Tinetti
Journal:  J Am Geriatr Soc       Date:  2012-10-04       Impact factor: 5.562

7.  Ethnic differences in respiratory impairment.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Thomas M Gill; John Concato; Philip H Quanjer; Peter H Van Ness
Journal:  Thorax       Date:  2013-08-12       Impact factor: 9.139

8.  Respiratory impairment in older persons: when less means more.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Philip H Quanjer; Peter H Van Ness; John Concato
Journal:  Am J Med       Date:  2012-11-20       Impact factor: 4.965

9.  Estimation of an Exposure Threshold Value for Compensation of Silica-Induced COPD Based on Longitudinal Changes in Pulmonary Function.

Authors:  Matthias Möhner; Dennis Nowak
Journal:  Int J Environ Res Public Health       Date:  2020-12-04       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.